SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

Clinical trial NCT07482020 · RECRUITING

Trial details

NCT number: NCT07482020
Sponsor: Huashan Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation (AF)Hypertension

Start date: 2025-03-01
Primary completion: 2026-12-30
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.